# FMC Corp: Form 10-Q for the period ended Sep 30, 2009

- Company: [FMC Corp](/companies/fmc.md) (CIK 37785)
- Form: 10-Q
- Filed: 2009-11-04
- Accepted by EDGAR: Nov 4, 2009, 19:54 ET
- Period: 2009-09-30
- Accession: 0001193125-09-223626
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/37785/000119312509223626/d10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/37785/000119312509223626/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2009-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2009-07-01 to 2009-09-30 | $713.3m | us-gaap:Revenues |
| Revenue | 9 months, 2009-01-01 to 2009-09-30 | $2.10bn | us-gaap:Revenues |
| Cost of revenue | 3 months, 2009-07-01 to 2009-09-30 | $510.0m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months, 2009-01-01 to 2009-09-30 | $1.44bn | us-gaap:CostOfRevenue |
| Selling, general and administrative | 3 months, 2009-07-01 to 2009-09-30 | $79.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2009-01-01 to 2009-09-30 | $234.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2009-07-01 to 2009-09-30 | $68.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2009-01-01 to 2009-09-30 | $279.2m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2009-07-01 to 2009-09-30 | $27.2m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2009-01-01 to 2009-09-30 | $74.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2009-07-01 to 2009-09-30 | $28.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2009-01-01 to 2009-09-30 | $166.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2009-07-01 to 2009-09-30 | $0.38 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2009-01-01 to 2009-09-30 | $2.27 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2009-07-01 to 2009-09-30 | $0.39 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2009-01-01 to 2009-09-30 | $2.30 | us-gaap:EarningsPerShareBasic |
| Operating cash flow | 9 months, 2009-01-01 to 2009-09-30 | $274.3m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 9 months, 2009-01-01 to 2009-09-30 | $106.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2009-01-01 to 2009-09-30 | $27.3m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months, 2009-01-01 to 2009-09-30 | $36.4m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2009-09-30 | $59.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2009-09-30 | $1.44bn | us-gaap:AssetsCurrent |
| Total assets | at 2009-09-30 | $3.05bn | us-gaap:Assets |
| Current liabilities | at 2009-09-30 | $765.2m | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2009-09-30 | $541.9m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2009-09-30 | $1.9m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2009-09-30 | $1.07bn | us-gaap:StockholdersEquity |
| Shares outstanding | at 2009-09-30 | 72,300,117 shares | dei:EntityCommonStockSharesOutstanding |

## Management's discussion and analysis

As filed, 68,986 characters.

Item 2 of this report contains certain forward-looking statements that are based on our current views and assumptions regarding future events, future business conditions and the outlook for our company based on currently available information.

Whenever possible, we have identified these forward-looking statements by such words or phrases as “will likely result”, “is confident that”, “expects”, “should”, “could”, “may”, “will continue to”, “believes”, “anticipates”, “predicts”, “forecasts”, “estimates”, “projects”, “potential”, “intends” or similar expressions identifying “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words or phrases. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the outlook for our company based on currently available information. The forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those expressed in, or implied by, these statements. These statements are qualified by reference to the section “Forward-Looking Statements” in Part II of our Annual Report on Form 10-K for the year ended December 31, 2008 (the “2008 10-K”) and to similar disclaimers in all other reports and forms filed with the Securities and Exchange Commission (“SEC”). We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made.

We further caution that the list of risk factors in Item 1A in Part 1 of the 2008 10-K may not be all-inclusive, and we specifically decline to undertake any obligation to publicly revise any forward-looking statements that have been made to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

### APPLICATION OF CRITICAL ACCOUNTING POLICIES

Our consolidated financial statements are prepared in conformity with U.S. generally accepted accounting principles. The preparation of our financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. We have described our accounting policies in Note 1 to our consolidated financial statements included in our 2008 10-K. We have reviewed these accounting policies, identifying those that we believe to be critical to the preparation and understanding of our consolidated financial statements. We have reviewed with the Audit Committee of our Board of Directors those accounting policies that we have deemed critical. Critical accounting policies are central to our presentation of results of operations and financial condition and require management to make estimates and judgments on certain matters. We base our estimates and judgments on historical experience, current conditions and other reasonable factors.

The following is a list of those accounting policies that we have deemed most critical to the presentation and understanding of our results of operations and financial condition. See the “Application of Critical Accounting Policies” section in our 2008 10-K for a detailed description of these policies and their potential effects on our results of operations and financial condition.

- Environmental
- Impairment and valuation of long-lived assets
- Pensions and other postretirement benefits
- Income taxes

We did not adopt any changes in the current period that had a material effect on these critical accounting policies nor did we make any changes to our accounting policies that would have changed these critical accounting policies.

### RECENTLY ISSUED AND ADOPTED ACCOUNTING PRONOUNCEMENTS

See Note 2 to our condensed consolidated financial statements included in this Form 10-Q for a discussion of recently adopted accounting guidance and other new accounting guidance.

### OVERVIEW

We are a diversified, global chemical company providing innovative solutions, applications and market leading products to a wide variety of markets. We operate in three distinct business segments: Agricultural Products, Specialty Chemicals and Industrial Chemicals. Our Agricultural Products segment develops, markets and sells all three major classes of crop protection chemicals – insecticides, herbicides, and fungicides – with particular strength in insecticides and herbicides. These products are used in agriculture to enhance crop yield and quality by controlling a broad spectrum of insects, weeds and disease, as well as pest control in non-agricultural markets. Specialty Chemicals consists of our BioPolymer and lithium businesses and focuses on food ingredients that are used to enhance texture, structure and physical stability, pharmaceutical additives for binding, encapsulation and disintegrant applications, ultrapure biopolymers for medical devices and lithium specialties for pharmaceutical synthesis, specialty polymers and energy storage. Our Industrial Chemicals segment manufactures a wide range of inorganic materials, including soda ash, hydrogen peroxide, specialty peroxygens and phosphorus chemicals.

### 2009 Highlights

Our businesses this year have each been affected by the downturn in the global economy but to varying degrees. Revenues in the aggregate are down 12 percent versus the first nine months of 2008. Our Industrial Chemicals segment has been most impacted with revenues down 22 percent year-to-date on lower volume due to weak global demand particularly in end markets for flat glass, detergents and pulp and paper. However, revenues in the third quarter are showing improving demand over the second quarter of 2009. Our Specialty Chemicals segment had mixed results with Lithium volumes down on weak end markets in industrial and electronics, while BioPolymer continued to grow revenue, on good commercial performance and from the alginates acquisition in the third quarter of 2008. Our Agricultural Products segment recognized lower revenues in most major markets with the exception of North America.

In response to these weaker market conditions, we took a number of decisions this year to realign some of our operating assets. During the first quarter, we made the decision to shut down the peroxygens’ manufacturing facility in Santa Clara, Mexico and the lithium facility in Bayport, Texas. During the second and third quarter, respectively, we made the decision to shut down Foret’s operations in Barcelona, Spain and to curtail soda ash operations at our Granger, Wyoming facility.

During the first half of 2009, we closed on two acquisitions in our Agricultural Products business. We acquired the CB Professional Products line of insect control products from Waterbury Companies, Inc. and the proprietary fungicide Benalaxyl from Isagro S.p.A. Both of these acquisitions fit our strategic goal of offering an expanding product portfolio in focused markets. Additionally, we announced plans at the beginning of this year to realign our BioPolymer alginates manufacturing operations in Norway and the United Kingdom as the company continues integration of the International Specialty Products (ISP) alginates business acquired in August 2008.

### RESULTS OF OPERATIONS

#### Overview

The following presents a reconciliation of our segment operating profit to net income attributable to FMC stockholders as seen through the eyes of our management. For management purposes, we report the operating performance of each of our business segments based on earnings before interest and income taxes excluding corporate expenses, other income (expense), net and corporate special income/(charges).

*(in Millions)*

| Revenue | Three Months Ended September 30, 2009 | 2008 | Nine Months Ended September 30, 2009 | 2008 |
| --- | ---: | ---: | ---: | ---: |
| Agricultural Products | $268.3 | $263.8 | $782.1 | $817.9 |
| Specialty Chemicals | 191.7 | 198.0 | 558.9 | 574.2 |
| Industrial Chemicals | 254.4 | 359.6 | 766.6 | 988.9 |
| Eliminations | (1.1) | (0.6) | (3.5) | (3.4) |
| Total | $713.3 | $820.8 | $2,104.1 | $2,377.6 |
| **Income (loss) from continuing operations before income taxes** |  |  |  |  |
| Agricultural Products | $59.2 | $44.1 | $242.2 | $211.5 |
| Specialty Chemicals | 40.9 | 35.9 | 119.5 | 116.9 |
| Industrial Chemicals | 20.7 | 67.3 | 57.0 | 148.1 |
| Eliminations | — | 0.2 | (0.1) | (0.1) |
| **Segment operating profit (1)** | 120.8 | 147.5 | 418.6 | 476.4 |
| Corporate | (10.3) | (12.5) | (31.9) | (37.4) |
| Other income (expense), net | (8.3) | (1.7) | (21.1) | (9.1) |
| Interest expense, net | (6.2) | (7.5) | (19.7) | (24.5) |
| Corporate special income (charges): |  |  |  |  |
| Restructuring and other income (charges) | (32.3) | (15.6) | (84.9) | (18.0) |
| Purchase accounting inventory fair value impact and other related inventory adjustments | (2.4) | (1.0) | (4.7) | (1.0) |
| Provision for income taxes | (27.2) | (23.3) | (74.2) | (108.0) |
| Discontinued operations, net of income taxes | (6.1) | (5.9) | (15.7) | (20.1) |
| **Net income attributable to FMC stockholders** | $28.0 | $80.0 | $166.4 | $258.3 |

(1) Results for all segments are net of noncontrolling interests of $1.4 million and $5.6 million in the three and nine months ended September 30, 2009, respectively and $4.7 million and $11.4 million in the three and nine months ended September 30, 2008, respectively. The majority of these noncontrolling interests pertain to our Industrial Chemicals segment.

The below chart, which is provided to assist readers of our financial statements, depicts certain after-tax charges (gains). These items are excluded by us in the measures we use to evaluate business performance and determine certain performance-based compensation. These after-tax items are discussed in detail within the “Other Results of Operations” section that follows.

| Net income includes the following after-tax charges (gains): | Three Months Ended September 30, 2009 | 2008 | Nine Months Ended September 30, 2009 | 2008 |
| --- | ---: | ---: | ---: | ---: |
| Corporate special charges (income), pre-tax | $34.7 | $16.6 | $89.6 | $19.0 |
| Income tax expense (benefit) on Corporate special charges (income) | (3.8) | (5.7) | (21.6) | (10.5) |
| Corporate special charges (income), net of income taxes | 30.9 | 10.9 | 68.0 | 8.5 |
| Discontinued operations, net of income taxes | 6.1 | 5.9 | 15.7 | 20.1 |
| Tax adjustments | 0.3 | (11.2) | (14.9) | (11.2) |

33

### Three months ended September 30, 2009 compared to Three months ended September 30, 2008

In the discussion below, please refer to our chart on page 33 under “Overview”. All comparisons are between the periods unless otherwise noted.

### Segment Results

For management purposes, segment operating profit is defined as segment revenue less operating expenses (segment operating expenses consist of costs of sales and services, selling, general and administrative expenses and research and development expenses). We have excluded the following items from segment operating profit: corporate staff expense, interest income and expense associated with corporate debt facilities and investments, income taxes, gains (or losses) on divestitures of businesses, restructuring and other charges, investment gains and losses, loss on extinguishment of debt, asset impairments, LIFO inventory adjustments, amortization of inventory step-up from business acquisitions and other related inventory adjustments, and other income and expense items.

Information about how each of these items relate to our businesses at the segment level is discussed in Note 20 of our condensed consolidated financial statements filed in this Form 10-Q and in Note 19 of our 2008 consolidated financial statements in our 2008 10-K.

### Agricultural Products

*(in Millions)*

|  | Three Months Ended September 30, 2009 | 2008 | Increase/(Decrease) $% |  |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $268.3 | $263.8 | $4.5 | 2% |
| Operating Profit | 59.2 | 44.1 | 15.1 | 34 |

Revenue in Agricultural Products of $268.3 million increased two percent versus the prior-year quarter, as sales gains in Brazil and non-crop markets were partially offset by lower volumes in North America and Europe. Revenue in Latin America increased seven percent due to growth in Brazil in planted acres for several key crops and market expansion into soybeans. North America revenues declined five percent mainly due to weaker insect infestations. Revenues in Europe were down nine percent on weaker market conditions and Asia was flat with the prior year period.

Operating Profit of $59.2 million increased 34 percent versus the year-ago quarter, reflecting the sales growth in Brazil, lower raw material costs and a recovery of indirect taxes in Brazil.

### Specialty Chemicals

*(in Millions)*

|  | Three Months Ended September 30, 2009 | 2008 | Increase/(Decrease) $% |  |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $191.7 | $198.0 | $(6.3) | (3)% |
| Operating Profit | 40.9 | 35.9 | 5.0 | 14 |

Revenue in Specialty Chemicals was $191.7 million, down three percent versus year ago quarter as strong commercial performance and the benefit of acquisitions in BioPolymer were largely offset by lower lithium volumes. Biopolymer sales increased six percent on stronger pharmaceutical markets and revenues from acquisitions closed in mid-third quarter of 2008, partially offset by the impacts of a weaker euro in the quarter. Lithium revenues were down 26 percent on continued weak markets across the business.

Operating Profit of $40.9 million was 14 percent higher than the year-ago quarter, as favorable commercial performance and the benefits of acquisitions in BioPolymer and a recovery of export taxes in Argentina were partially offset by lower lithium volumes.

### Industrial Chemicals

*(in Millions)*

|  | Three Months Ended September 30, 2009 | 2008 | Increase/(Decrease) $% |  |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $254.4 | $359.6 | $(105.2) | (29)% |
| Operating Profit | 20.7 | 67.3 | (46.6) | (69) |

Revenue in Industrial Chemicals of $254.4 million declined 29 percent from the prior-year quarter. Volume declines reduced revenues by 16 percent across the segment and pricing declined five percent as lower prices for phosphates more than offset the pricing improvements in other product lines. Unfavorable currency translation, lower freight billings and lower revenue from electricity sales in Foret further reduced revenues by eight percent. Soda ash volumes in the third quarter were sequentially higher than to second quarter 2009 volumes but remain below their prior-year level. While soda ash pricing was favorable to revenue overall, domestic selling prices for soda ash continued to be higher than prior-year, while export prices have declined sequentially as market share has been regained. In our North American peroxygens business, the higher selling prices and stronger performance in specialty applications have been more than offset by lower hydrogen peroxide volumes due mainly to weaker pulp and paper markets. In Foret, revenues declined on lower volumes, reduced phosphate pricing and unfavorable currency translation.

Operating Profit of $20.7 million was 69 percent lower than the year-ago quarter, driven by the lower sales partially offset by lower energy and raw material costs, primarily phosphate rock.

### Other Results of Operations

#### Corporate expenses

We recorded charges of $10.3 million in the third quarter of 2009 compared to $12.5 million in third quarter of 2008. The decrease was primarily due to reduced incentive compensation expenses and reductions in discretionary spending in the third quarter of 2009 compared to the same period in 2008. Corporate expenses are included as a component of the line item “Selling, general and administrative expenses” on our condensed consolidated statements of income.

#### Other income (expense), net

Other income (expense), net is comprised primarily of last-in, first-out (“LIFO”) inventory adjustments and pension expense. Other expense increased to $8.3 million in the third quarter of 2009 from $1.7 million in the same period of 2008. The increase was due primarily to higher pension expense and an increase to the mark to market impact of our deferred compensation liability. Other income (expense), net is included as a component of the line item “Costs of sales and services” on our condensed consolidated statements of income.

#### Interest expense, net

Interest expense, net for the third quarter of 2009 was $6.2 million as compared to $7.5 million in the third quarter of 2008. The decrease was due to lower interest rates on the borrowings under our credit agreements as compared to the prior period.

#### Corporate special income (charges)

*Restructuring and other charges (income)* totaled $32.3 million in the third quarter of 2009. Charges (income) in this category for the quarter ended September 30, 2009 include the following:

- A $5.5 million charge in our Industrial Chemicals segment due to our decision to phase out operations of our Barcelona, Spain facility. The charge consisted of accelerated depreciation on fixed assets to be abandoned of approximately $7.7 million offset by a $2.2 million benefit due to a reduction in our estimated severance and employee benefits for the shutdown that had been accrued in the second quarter of 2009.
- A $3.6 million charge in our Specialty Chemicals segment due to the realignment of our BioPolymer alginates manufacturing operations. The charge consisted of (i) accelerated depreciation on fixed assets to be abandoned of approximately $3.2 million and (ii) severance and employee benefits of $0.4 million.
- A $2.3 million net gain as a result of exiting our leases at our Princeton facility.
- A gain of $1.0 million as a result of the sale of our sodium sulfate co-generation facility.
- A $1.0 million charge related to our Agricultural Products segment acquiring further rights under a collaboration and license agreement with a third-party company.
- A charge of $21.0 million related to the resolution of a regulatory matter in our Industrial Chemicals segment.
- $7.1 million of severance costs due to other workforce restructurings, of which $5.8 million related to our Industrial Chemicals segment and $1.3 million related to our Specialty Chemicals segment.
- Other asset abandonment charges of $1.6 million, of which $1.1 million related to our Industrial Chemicals segment and $0.5 million related to our Specialty Chemicals segment.
- A Corporate net gain of $4.9 million representing recoveries partially offset by charges related to continuing environmental sites.
- $0.7 million of other charges, related to adjustments related to previously recorded restructuring reserves.

Restructuring and other charges (income) totaled $15.6 million in the third quarter of 2008 primarily as a result of charges of $0.6 million related to the phase-out of our Agricultural Products chemical facility in Baltimore, Maryland, and $2.3 million related to the phase-out of operations at our Jacksonville, Florida facility, both of which are in our Agricultural Products segment. Additional charges include restructuring related severance charges in our Agricultural Products segment, Industrial Chemicals segment and Specialty Chemicals segment ($1.6 million, $0.8 million and $0.3 million, respectively), asset abandonment charges in our Agricultural Products segment, Industrial Chemicals segment and Specialty Chemicals segment ($0.6 million, $0.3 million and $3.3 million, respectively) and charges associated with further rights acquired from a collaboration and license agreement in our Agricultural Products segment ($1.0 million). Remaining restructuring and other charges (income) for the three months ended September 30, 2008 included $0.5 million of other charges primarily related to our Industrial Chemicals segment and charges associated with continuing environmental sites as a Corporate charge ($4.3 million).

*Purchase accounting inventory fair value impact and other related inventory adjustments* for the three months ended September 30, 2009 represents inventory adjustments related to the third quarter 2008 acquisition in our Specialty Chemicals segment and subsequent alginates business restructuring. For the three months ended September 30, 2008, the charges represent the amortization of the inventory fair value step-up resulting from the application of purchase accounting associated with the third quarter 2008 acquisition in our Specialty Chemicals segment. On the condensed consolidated statements of income, these charges are included in “Costs of sales and services”.

#### Provision for income taxes

We recorded a provision of $27.2 million for the third quarter of 2009 compared to a provision of $23.3 million for the prior period resulting in effective tax rates of 43.4 percent and 20.5 percent, respectively. The increase in the effective tax rate was primarily a result of a change in the mix of domestic income compared to income earned outside of the U.S. and a charge in 2009 related to the resolution of a regulatory matter in our Industrial Chemicals segment that is nondeductible for tax purposes. The change in the rate was also the result of a $10.4 million benefit in 2008 to adjust our reserve for unrecognized tax benefits due to favorable conclusions of tax audits.

#### Discontinued operations, net of income taxes

Our discontinued operations represent adjustments to retained liabilities primarily related to operations discontinued between 1976 and 2001. The primary liabilities retained include environmental liabilities, other post-retirement benefit liabilities, self-insurance and long-term obligations related to legal proceedings.

Discontinued operations, net of income taxes totaled a loss of $6.1 million for the three months ended September 30, 2009 compared to a loss of $5.9 million for the three months ended September 30, 2008. The loss for the three months ended September 30, 2009 primarily related to charges to increase our reserve for operating and maintenance activities and charges for legal reserves and expenses related to discontinued operations partially offset by recoveries related to our Front Royal site. The loss for the three months ended September 30, 2008 is primarily the result of environmental charges associated with our Front Royal site and charges for legal reserves and expenses related to discontinued operations.

#### Net income attributable to FMC stockholders

Net income attributable to FMC stockholders decreased to $28.0 million for the three months ended September 30, 2009 from $80.0 million for the three months ended September 30, 2008. The decrease was primarily due to lower Industrial Chemicals segment operating profit and higher restructuring and other charges (income). Partially offsetting this was higher profits in our Agricultural Products segment.

### Nine months ended September 30, 2009 compared to Nine months ended September 30, 2008

In the discussion below, please refer to our chart on page 33 under “Overview”. All comparisons are between the periods unless otherwise noted.

### Segment Results

### Agricultural Products

*(in Millions)*

|  | Nine Months Ended September 30, 2009 | 2008 | Increase/(Decrease) $% |  |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $782.1 | $817.9 | $(35.8) | (4)% |
| Operating Profit | 242.2 | 211.5 | 30.7 | 15 |

Revenue in Agricultural Products was $782.1 million, a decrease of four percent versus the prior-year period, as sales gains in North America and generally higher pricing across the business were more than offset by lower sales in Latin America, primarily Brazil, and unfavorable currency impacts in Europe and Asia. North American revenues increased eight percent on new product introductions, price increases and sales from the CB Professional Products line acquisition. Europe revenues declined 15 percent on weaker markets and unfavorable currency impacts. Latin America revenues declined six percent due to weaker demand in sugar cane and cotton in the first half of the year. Asia revenues declined seven percent due mainly to unfavorable weather conditions, weak pest pressures and unfavorable currency impacts.

Operating Profit of $242.2 million increased 15 percent from the prior year period as a result of higher selling prices, favorable product and geographic mix, continued global supply chain productivity improvements and lower selling and administrative expenses.

In 2009, full-year revenue will be level to prior year as growth in North America and higher selling prices in most regions is offset by unfavorable currency impacts and weaker market conditions in parts of Europe and Asia. Full-year segment operating profit is expected to be up in the high teens, reflecting higher selling prices, continued supply chain productivity improvements, lower raw material costs and lower selling and administrative expense.

In our Agricultural Products segment, several products are undergoing re-registration in the U.S. and/or a comparable regulatory review by the European Union (“EU”) governmental authorities. In August 2006, the U.S. Environmental Protection Agency issued its “Interim Reregistration Eligibility Decision” (“IRED”) for our carbofuran insecticide. The IRED proposes cancellation of all carbofuran uses in the United States, subject to a phase out period for certain minor crop uses while maintaining tolerances for imported commodities (bananas, coffee, rice and sugarcane). The EPA reiterated its proposal in January 2008 with the issuance of a draft Notice of Intent to Cancel. In February 2008, the EPA convened a Scientific Advisory Panel meeting to evaluate scientific issues relevant to the draft Notice of Intent to Cancel carbofuran. Separately, the U.S. Department of Agriculture issued its comments on the draft cancellation notice, stating that carbofuran should continue to be registered. On July 24, 2008, the EPA published a proposal to revoke all carbofuran tolerances under the Federal Food Drug and Cosmetic Act in advance of any issuance of a final Notice of Intent to Cancel under the federal pesticide law. We responded to that notice, expressing our strong disagreement with the EPA’s proposal to revoke tolerances and our belief that carbofuran residues on food do not pose a threat to human health. In May 2009, the EPA published its final revocation of all carbofuran tolerances effective December 31, 2009. We have filed our objections to this revocation and have requested a hearing before an administrative law judge. Meanwhile, FMC can continue to sell carbofuran in the United States at this time. On October 30, 2009, EPA issued its decision to deny our objections and request for a hearing. We believe that we are entitled to a hearing and we intend to challenge this decision by seeking judicial review in the US federal courts. FMC’s sales of carbofuran in the United States are not significant and are expected to end in 2009. The outcome of any litigation to compel a hearing is uncertain. We do not know the EPA’s timing on a final Notice of Intent to Cancel the carbofuran registration, though the EPA has said it intends to issue such notice after the tolerance revocation decision.

In June 2007, the European Commission published its decisions not to include carbofuran, carbosulfan and cadusafos on the official list of active ingredients approved for continued sale in the EU. The published decisions required EU Member States to de-register the products within six months, and so FMC ceased its sales of these products in December 2007. We disagreed with the Commission’s decisions and underlying assessment. We have re-submitted cadusafos, carbofuran and carbosulfan for approval on the official list. The outcome of our regulatory resubmissions is uncertain.

Also in the EU, in March 2009 the Commission proposed not to include our pyrethroid insecticide bifenthrin on the official list, but the Standing Committee rejected that proposal. The regulatory decision was referred to the EU Council of Ministers. In July 2009, the process concluded whereby the Commission’s non-inclusion proposal will now be implemented. The non-inclusion decision is expected to be adopted in November 2009 and we anticipate that FMC will have an additional six months to sell bifenthrin, and subsequently, in most countries, there will be up to 6-12 months for further sale and use. Accordingly, sales of bifenthrin will continue throughout 2009 and we anticipate only a modest impact in 2010. We will re-submit immediately for reconsideration upon publication of the official decision and thereby seek to minimize any interruption in sales.

We intend to defend vigorously all our products in the U.S., EU and other countries’ regulatory processes where FMC’s pesticide products will be reviewed in the ordinary course of regulatory programs during 2009 as part of the ongoing cycle of re-registration in countries around the world. Recently, the Brazilian health agency has informed us that they intend to review carbofuran along with 13 other major pesticides before year end 2009. FMC is cooperating and defending our product in this process. Under the Brazilian regulatory process, any recommendation would need public notice and comment as well as concurrence from the Brazilian environmental and agricultural ministries before any regulatory change is effective. Thus, we do not expect a potential sales impact in 2010, if any.

### Specialty Chemicals

*(in Millions)*

|  | Nine Months Ended September 30, 2009 | 2008 | Increase/(Decrease) $% |  |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $558.9 | $574.2 | $(15.3) | (3)% |
| Operating Profit | 119.5 | 116.9 | 2.6 | 2 |

Revenue in Specialty Chemicals was $558.9 million, three percent lower than the prior-year period. BioPolymer revenues increased eight percent, mainly as a result of price increases and the acquisitions in mid-third quarter of 2008, partially offset by the impacts of a weaker euro. Lithium revenues declined 28 percent on weak demand across the business.

Operating Profit of $119.5 million increased two percent versus the year-earlier period as favorable commercial performance in BioPolymer, productivity initiatives and a recovery of export taxes in Argentina were partially offset by lower lithium volumes, temporary plant curtailments to reduce inventories and unfavorable currency translation.

In 2009, full-year revenue is expected to be level with prior year, as higher volumes and selling prices in BioPolymer are offset by lower lithium volumes. Full-year segment operating profit is expected to be up in the mid-single digits driven by strong BioPolymer results partially offset by lower lithium performance.

### Industrial Chemicals

*(in Millions)*

|  | Nine Months Ended September 30, 2009 | 2008 | Increase/(Decrease) $% |  |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $766.6 | $988.9 | $(222.3) | (22)% |
| Operating Profit | 57.0 | 148.1 | (91.1) | (62) |

Revenue in Industrial Chemicals was $766.6 million, a decrease of 22 percent versus the prior-year period. Volume declines across the segment reduced revenues by 19 percent, which was partially offset by a three percent increase in pricing, despite a significant year-over-year reduction in pricing for phosphates. Soda ash revenues were down on lower volumes, with pricing improvements, partially offsetting these unfavorable impacts. In peroxygens, the lower revenue on volume declines was also partially offset by pricing improvements. Foret revenues are down on lower volumes and pricing, particularly for phosphates and an unfavorable euro.

Segment earnings of $57.0 million declined 62 percent versus the year-earlier period, driven by lower volumes and higher raw material costs, particularly phosphate rock, which more than offset favorable pricing.

In 2009, full-year revenue is expected to be down approximately 20 percent as higher selling prices in most businesses are more than offset by lower volumes across the segment, reduced phosphate selling prices and unfavorable currency translation. Full-year segment operating profit is expected to be down 55 percent driven primarily by lower volumes across the segment and reduced phosphate selling prices.

### Other Results of Operations

#### Corporate expenses

We recorded charges of $31.9 million in the first nine months of 2009 compared to $37.4 million in the first nine months of 2008. This decrease was primarily due to reduced incentive compensation expense and reductions in discretionary spending in the first nine months of 2009 compared to the same period in 2008. Corporate expenses are included as a component of the line item “Selling, general and administrative expenses” on our condensed consolidated statements of income.

#### Other income (expense), net

Other income (expense), net is comprised primarily of LIFO inventory adjustments and pension expense. Other expense increased to $21.1 million of expense in the first nine months of 2009 from $9.1 million of expense in the same period of 2008. The increase was due primarily to higher charges related to our LIFO inventory reserves, higher pension expense and an increase to the mark to market impact of our deferred compensation liability. Other income (expense), net is included as a component of the line item “Costs of sales and services” on our condensed consolidated statements of income.

#### Interest expense, net

Interest expense, net for the first nine months of 2009 was $19.7 million as compared to $24.5 million in the first nine months of 2008. The decrease was due to lower interest rates on the borrowings under our credit agreements as compared to the prior period.

#### Corporate special income (charges)

*Restructuring and other charges (income)* totaled $84.9 million in the nine months ended September 30, 2009. Charges (income) in this category for the nine months ended September 30, 2009 include the following:

- An $18.0 million charge in our Industrial Chemicals segment due to our decision to phase out operations of our Barcelona, Spain facility. The charge consisted of (i) severance and employee benefits of 10.3 million and (ii) accelerated depreciation on fixed assets to be abandoned of approximately $7.7 million.
- A $9.9 million charge in our Specialty Chemicals segment due to the realignment of our BioPolymer alginates manufacturing operations. The charge consisted of (i) accelerated depreciation on fixed assets to be abandoned of approximately $6.5 million, (ii) severance and employee benefits of $3.2 million and (iii) other shut down charges of $0.2 million.
- A $7.6 million charge in our Specialty Chemicals segment due to our decision to close our Bayport butyllithium facility located in Bayport, Texas. The charge consisted of (i) accelerated depreciation on fixed assets to be abandoned of approximately $6.9 million and (ii) severance and employee benefits of $0.7 million.
- A $6.6 million charge in our Industrial Chemicals segment due to our decision to shut down our manufacturing operations at our Peroxygens facility in Santa Clara, Mexico. The charge consisted of (i) accelerated depreciation on fixed assets to be abandoned of approximately $3.4 million, (ii) severance and employee benefits of $1.5 million and (iii) other shut down costs of approximately $1.7 million.
- Charges of $2.0 million related to our Agricultural Products segment acquiring further rights under a collaboration and license agreement with a third-party company.
- A $1.5 million charge in our Agricultural Products segment due to our decision to phase-out operations at our Baltimore, Maryland agricultural chemicals facility. The charge consisted of (i) demolition costs of $1.0 million and (ii) other shutdown costs of $0.5 million. We ceased production at this facility in the second quarter of 2008.
- A $2.3 million net gain as a result of exiting our leases at our Princeton facility.
- A gain of $1.0 million as a result of the sale of our sodium sulfate co-generation facility.
- A charge of $21.0 million related to the resolution of a regulatory matter in our Industrial Chemicals segment.
- $11.6 million of severance costs due to other workforce restructurings, of which $9.5 million related to our Industrial Chemicals segment and $2.1 million related to our Specialty Chemicals segment.
- Other asset abandonment charges of $6.8 million, of which $2.6 million related to our Agricultural Products segment, $2.6 million related to our Industrial Chemicals segment and $1.6 million related to our Specialty Chemicals segment.
- A Corporate gain of $0.9 million representing recoveries mostly offset by charges related to continuing environmental sites.
- $4.1 million of other charges, primarily relating to settlements with state authorities for property claims and adjustments related to previously recorded restructuring reserves.

Restructuring and other charges (income) totaled $18.0 million for the nine months ended September 30, 2008. This amount includes a $29.6 million gain related to the sale of the Princeton property and a gain of $3.6 million related to the sale of Foret’s sodium sulfate assets. Foret is part of our Industrial Chemicals segment. These gains were more than offset by restructuring charges of $22.2 million related to the phase-out of the Agricultural Products chemical facility in Baltimore, Maryland and $4.9 million related to the phase-out of operations at our Jacksonville, Florida facility, both of which are in our Agricultural Products segment. We also incurred charges associated with continuing environmental sites as a Corporate charge ($10.3 million), restructuring related severance charges in our Agricultural Products segment, Industrial Chemicals segment and Specialty Chemicals segment ($3.4 million, $2.8 million and $0.5 million, respectively) and asset abandonment charges in our Agricultural Products segment, Industrial Chemicals segment and Specialty Chemicals segment ($0.6 million, $0.7 million and $3.3 million, respectively). Remaining restructuring and other charges (income) for the nine months ended September 30, 2008 included $1.5 million of other charges primarily related to our Industrial Chemicals segment and charges associated with further rights acquired from a collaboration and license agreement in our Agricultural Products segment ($1.0 million).

*Purchase accounting inventory fair value impact and other inventory related adjustments* for the nine months ended September 30, 2009 represents $1.8 million in charges related to amortization of the inventory fair value step-up resulting from the application of purchase accounting associated with the third quarter 2008 acquisition in our Specialty Chemicals segment and the first quarter 2009 acquisition in our Agricultural Products segment. Additionally the amount in 2009 includes $2.9 million of inventory adjustments related to the third quarter 2008 acquisition in our Specialty Chemicals segment and subsequent alginates business restructuring. For the nine months ended September 30, 2008, the charges represent the amortization of inventory fair value step-up resulting from the application of purchase accounting associated with the third quarter 2008 acquisition in our Specialty Chemicals segment. On the condensed consolidated statements of income these charges are included in “Costs of sales and services”.

#### Provision for income taxes

We recorded a provision of $74.2 million for the first nine months of 2009 compared to a provision of $108.0 million for the prior period resulting in effective tax rates of 28.3 percent and 27.1 percent, respectively. The change in the effective tax rate was a result of a change in the mix of domestic income compared to income earned outside of the U.S. and a charge in 2009 related to the resolution of a regulatory matter in our Industrial Chemicals segment that is nondeductible for tax purposes. This was offset by a reduction in our liability in 2009 for unrecognized tax benefits of approximately $18 million as a result of settlements of audits and expiration of statute of limitations and a $10.4 million benefit in 2008 to adjust our reserve for unrecognized tax benefits due to favorable conclusions of tax audits.

#### Discontinued operations, net of income taxes

Our discontinued operations represent adjustments to retained liabilities primarily related to operations discontinued between 1976 and 2001. The primary liabilities retained include environmental liabilities, other post-retirement benefit liabilities, self-insurance and long-term obligations related to legal proceedings.

Discontinued operations, net of income taxes totaled a loss of $15.7 million for the nine months ended September 30, 2009 compared to a loss of $20.1 million for the nine months ended September 30, 2008. The loss for the nine months ended September 30, 2009 primarily related to charges to increase our reserve for operating and maintenance activities and charges for legal reserves and expenses related to discontinued operations partially offset by recoveries related to our Front Royal site. The loss for the nine months ended September 30, 2008 is primarily the result of environmental charges associated with our Front Royal and Middleport sites and charges for legal reserves and expenses related to discontinued operations.

#### Net income attributable to FMC stockholders

Net income attributable to FMC stockholders decreased to $166.4 million for the nine months ended September 30, 2009 from $258.3 million for the nine months ended September 30, 2008. The decrease was primarily due to lower Industrial Chemicals segment operating profit and significantly higher restructuring and other charges (income). Partially offsetting this was higher profits in our Agricultural Products segment and a reduction in interest expense.

### LIQUIDITY AND CAPITAL RESOURCES

Cash and cash equivalents at September 30, 2009 and December 31, 2008 were $59.9 million and $52.4 million, respectively. At September 30, 2009, we had total debt of $613.6 million as compared to $623.6 million at December 31, 2008. This included $541.9 million and $592.9 million of long-term debt (excluding current portions of $1.9 million and $2.1 million) at September 30, 2009 and December 31, 2008, respectively. Short-term debt, which consists solely of foreign borrowings, increased to $69.8 million at September 30, 2009 compared to $28.6 million at December 31, 2008.

#### Domestic Credit Agreement

On August 28, 2007, we executed a new credit agreement (the “Domestic Credit Agreement”) which provided for a five-year, $600 million revolving credit facility. The proceeds from this facility are available for general corporate purposes, including issuing letters of credit up to a $300 million sub-limit. The Domestic Credit Agreement also contains an option under which, subject to certain conditions, we may request an increase in the facility to $1 billion.

There were no borrowings under the new facility at inception, and our prior credit agreement dated as of June 21, 2005 was terminated. Obligations under the prior credit agreement and related transaction costs, fees, and expenses for the new Agreement were paid with available cash. Loans under the facility bear interest at a floating rate, either a base rate as defined or the applicable euro currency rate for the relevant term plus an applicable margin. At September 30, 2009, the applicable euro currency margin was 0.35 percent, subject to adjustment based on the credit rating assigned to our senior unsecured debt. At September 30, 2009, borrowing rates under our Domestic Credit Agreement ranged from 0.6 to 3.3 percent per annum.

We had $127.0 million of borrowings under our Domestic Credit Agreement at September 30, 2009 compared to $203.0 million of borrowings at December 31, 2008. Letters of credit outstanding under the Domestic Credit Agreement totaled $152.9 million and $151.5 million at September 30, 2009 and December 31, 2008, respectively. As such, available funds under the Domestic Credit Agreement were $320.1 million and $245.5 million at September 30, 2009 and December 31, 2008, respectively.

#### European Credit Agreement

On December 16, 2005, our Dutch finance subsidiary executed a credit agreement (the “European Credit Agreement”) which provides for an unsecured revolving credit facility in the amount of €220 million. Borrowings may be denominated in euros or U.S. dollars. FMC and our Dutch finance subsidiary’s direct parent provide guarantees of amounts due under the European Credit Agreement.

Loans under the European Credit Agreement bear interest at a euro currency base rate, which for loans denominated in euros is the Euro InterBank Offered Rate, and for loans denominated in dollars is London Interbank Offered Rate (“LIBOR”) in each case plus a margin. The applicable margin under our European Credit Agreement is subject to adjustment based on the credit rating assigned to our senior unsecured debt. At September 30, 2009, the applicable margin was 0.35 percent and the applicable borrowing rate under the European Credit Agreement ranged from 0.8 to 2.1 percent per annum.

At September 30, 2009, we had $159.9 million in U.S. dollar equivalent revolving credit facility borrowings under the European Credit Agreement compared to $157.2 million at December 31, 2008. Available funds under this facility were $161.4 million and $150.2 million at September 30, 2009 and December 31, 2008, respectively.

Among other restrictions, the Domestic Credit Agreement and the European Credit Agreement contain financial covenants applicable to FMC and its consolidated subsidiaries related to leverage (measured as the ratio of debt to adjusted earnings) and interest coverage (measured as the ratio of adjusted earnings to interest expense). Our actual leverage for the four consecutive quarters ended

September 30, 2009 was 1.2 which is below the maximum leverage 3.5. Our actual interest coverage for the four consecutive quarters ended September 30, 2009 was 20.4 which is above the minimum interest coverage of 3.5. We were in compliance with all covenants at September 30, 2009.

#### Statement of Cash Flows

Cash provided by operating activities was $274.3 million for the nine months ended September 30, 2009. Net income from continuing operations of $182.1 million reflects the weaker business conditions experienced to date. Included in our net income was $84.9 million of restructuring and other charges most of which was for non-cash asset write downs, severance costs which will not be paid until 2010 and charges for legal issues that have not yet been settled. Cash expended on restructuring and other charges of $30.1 million was mainly for provisions taken in 2008. Receivables increased $25 million despite the lower revenues this year due to the mix of Agricultural Product sales in Brazil. Accounts payable were lower by $103.2 million as we paid for the higher price phosphate rock in Foret. We contributed $86.1 million to pension and other postretirement benefit plans including $75 million to our US qualified pension plan.

Cash provided by operating activities was $317.2 million for the nine months ended September 30, 2008. Receivables increased $128.3 million as our revenues continued to grow during the first nine months of 2008. Inventories increased to service the higher trading volumes and included some of the high cost phosphorous rock in Foret. Similarly, accounts payable increased $40 million as we acquired these inventories. We contributed $42.7 million to pension and other postretirement benefit plans including $30 million to our US qualified pension plan.

Cash required by operating activities of discontinued operations was $31.1 million for the first nine months of 2009 compared to cash required of $37.8 million for the first nine months of 2008. This change was primarily due to decreased environmental spending in the nine months ended September 30, 2009.

Cash required by investing activities was $141.2 million for the nine months ended September 30, 2009 compared to cash required of $141.3 million for the nine months ended September 30, 2008. The change was driven primarily by reduced spending on acquisitions in 2009 offset by the significant reduction of proceeds from the sale of the properties and assets during the nine months ended September 30, 2009 as compared to the same period in 2008. Additionally, capital expenditures for the nine months ended September 30, 2009 were approximately $20 million less than the prior year period.

Cash required by financing activities was $96.5 million for the nine months ended September 30, 2009 compared to cash required of $115.6 million for the nine months ended September 30, 2008. This change is due primarily to an increase in our short-term debt, a reduction in repurchases of stock, and a reduction in repayments of long-term debt partially offset by higher repayments under our committed credit facilities.

### Other potential liquidity needs

Our cash needs for 2009 include operating cash requirements, capital expenditures, scheduled mandatory payments of long-term debt, dividend payments, contributions to our pension plans, environmental spending and restructuring. We plan to meet our liquidity needs through available cash, cash generated from operations and borrowings under our committed revolving credit facilities. We continually evaluate our options for divesting real estate holdings and property, plant and equipment that are no longer integral to any of our core operating businesses.

Projected 2009 capital expenditures are expected to be approximately 10 percent lower than 2008 levels.

Projected 2009 spending includes approximately $30 million of net environmental remediation spending. This spending does not include expected spending of approximately $15 million in 2009 on capital projects relating to environmental control facilities. Also, we expect to spend approximately $25 million in 2009 for environmental compliance costs, which we will include as a component of costs of sales and services in our consolidated statements of income since these amounts are not covered by established reserves. Capital spending to expand, maintain or replace equipment at our production facilities may trigger requirements for upgrading our environmental controls, which may increase our spending for environmental controls above the foregoing projections.

During 2008, the world equity markets were down significantly, exemplified by the S&P 500 index in the U.S. being down 37 percent. Our U.S. qualified defined benefit pension plan (“U.S. Plan”) assets fell from $829.4 million at December 31, 2007 to $563.9 million at December 31, 2008. Our U.S. Plan assets comprise approximately 93 percent of our total plan assets with the difference representing plan assets related to foreign pension plans. We have reduced our expected return on our U.S. Plan assets from 8.75 percent in 2008 to 8.5 percent in 2009. In developing the assumption for the long-term rate of return on assets for our U.S. Plan, we take into consideration the technical analysis performed by our outside actuaries, including historical market returns, information on the assumption for long-term real returns by asset class, inflation assumptions, and expectations for standard deviation related to these best estimates. We also consider the historical performance of our own plan’s trust, which has earned a compound annual rate of return of approximately 9.51 percent over the last 20 years (which is in excess of comparable market indices for the same period) as well as other factors. Given an actively managed investment portfolio, the expected annual rates of return by asset class for our portfolio, using geometric averaging, and after being adjusted for an estimated inflation rate of approximately 2.75 percent, is between 8.75 percent and 10.75 percent for equities, and between 4.25 percent and 7.75 percent for fixed-income investments, which generates a total expected portfolio return that is in line with our assumptions for the rate of return on assets. This lower expected return on plan assets, along with decreased assets and the amortization of actuarial losses primarily associated with the equity market decline in 2008 are estimated to increase our net periodic benefit costs by approximately $5.7 million during 2009 compared to 2008. Under The Pension Protection Act of 2006, we are not required to make a minimum level of funding into the U.S. Plan during 2009, however, in order to reduce future funding volatility we contributed $75 million in 2009 versus $30 million contributed in 2008 and 2007. We do not believe that the additional contribution will have a significant negative impact on our current and future liquidity needs. However a continuation of the volatility of interest rates and negative equity returns under current market conditions may require greater contributions to the Plan in the future.

On October 15, 2009, we paid dividends aggregating $9.1 million to our shareholders of record as of September 30, 2009. This amount is included in “Accrued and other liabilities” on the condensed consolidated balance sheets as of September 30, 2009. For the nine months ended September 30, 2009 and September 30, 2008, we paid $27.3 million and $25.1 million in dividends, respectively.

In April 2007, the Board of Directors authorized the repurchase of up to $250 million of our common stock. In October 2008, the Board authorized the repurchase of up to an additional $250 million of our common stock. Although the repurchase program does not include a specific timetable or price targets and may be suspended or terminated at any time, we expect that the program will be accomplished over a two-year period. Shares may be purchased through open market or privately negotiated transactions at the discretion of management based on its evaluation of market conditions and other factors. We also reacquire shares from time to time in connection with the vesting and exercise of awards under our equity compensation plans. During the nine months ended September 30, 2009, we repurchased 684,681 shares under the publicly announced repurchase program for $35 million.

### Commitments

We provide guarantees to financial institutions on behalf of certain Agricultural Products customers, principally in Brazil, for their seasonal borrowing. The total of these guarantees was $44.2 million and $20.3 million at September 30, 2009 and December 31, 2008, respectively, and are recorded on the condensed consolidated balance sheets for each date as “Guarantees of vendor financing”.

We also guarantee repayment of some of the borrowings of certain foreign affiliates accounted for using the equity method for investments. The other equity investors provide parallel agreements. As of September 30, 2009, these guarantees had maximum potential payments of $8.5 million as compared to $6.8 million as of December 31, 2008.

Short-term debt consisted of foreign credit lines at September 30, 2009 and December 31, 2008. We provide parent-company guarantees to lending institutions providing credit to our foreign subsidiaries.

In connection with our property and asset sales and divestitures, we have agreed to indemnify the buyer for certain liabilities, including environmental contamination and taxes that occurred prior to the date of sale. Our indemnification obligations with respect to these liabilities may be indefinite as to duration and may or may not be subject to a deductible, minimum claim amount or cap. As such, it is not possible for us to predict the likelihood that a claim will be made or to make a reasonable estimate of the maximum potential loss or range of loss. If triggered, we may be able to recover certain of the indemnity payments from third parties. We have not recorded any specific liabilities for these guarantees.

We spun off FMC Technologies, Inc. (“Technologies”) in 2001. At this time, we entered into a tax sharing agreement wherein each company is obligated for those taxes associated with its respective business, generally determined as if each company filed its own consolidated, combined or unitary tax returns for any period where Technologies is included in the consolidated, combined or unitary tax return of us or our subsidiaries. The statute of limitations for the 2001 U.S. federal income tax year has now closed and no questions regarding the spin-off were raised during the IRS audit for 2000-2001, therefore any liability for taxes if the spin-off of Technologies were not tax free due to an action taken by Technologies has been favorably concluded. The tax sharing agreement continues to be in force with respect to certain items, which we do not believe would have a material effect on our financial condition or results of operations.

We agreed to guarantee the performance by Technologies of a debt instrument (see Note 19 to the condensed consolidated financial statements in this Form 10-Q). These guaranteed obligations totaled $0.8 million as of September 30, 2009 and December 31, 2008.

### Contingencies

On January 28, 2005, we and our wholly owned subsidiary Foret received a Statement of Objections from the European Commission concerning alleged violations of competition law in the hydrogen peroxide business in Europe during the period 1994 to 2001. All of the significant European hydrogen peroxide producers also received the Statement of Objections. We and Foret responded to the Statement of Objections in April 2005 and a hearing on the matter was held at the end of June 2005. On May 3, 2006, we received a notice from the European Commission indicating that the Commission had imposed a fine on us and Foret in the aggregate amount of €25.0 million as a result of alleged violations during the period 1997-1999. In connection with this fine, we recorded an expense of $30.0 million (reflecting then-prevailing exchange rates) in our consolidated statements of income for the year ended December 31, 2006. This expense was included as a component of restructuring and other charges (income). Since we are not required to make the payment during the appeal process, which may extend beyond one year, the liability has been classified as long-term in the condensed consolidated balance sheets as of September 30, 2009 and December 31, 2008. Both we and Foret have appealed the decision of the Commission. During the appeal process, interest accrues on the fine at a rate, which as of September 30, 2009, was 4.0 percent per annum. We have provided a bank letter of credit in favor of the European Commission to guarantee our payment of the fine and accrued interest. At September 30, 2009, the amount of the letter of credit was €29.3 million (U.S. $42.8 million).

In February 2005 putative direct and indirect purchaser class action complaints were filed against six U.S. hydrogen peroxide producers (and certain of their foreign affiliates) in various federal courts alleging violations of antitrust laws. Federal law provides that persons who have been injured by violations of federal antitrust law may recover three times their actual damage plus attorney fees. Related cases were also filed in various state courts. All of the federal court cases were consolidated in the United States District Court for the Eastern District of Pennsylvania (Philadelphia). The District Court certified the direct purchaser class in January 2007. On December 30, 2008, the Court of Appeals vacated the class certification order and remanded the case for further proceedings in the District Court. Shortly thereafter, FMC reached an agreement to settle with the direct purchaser class for $10 million, with a pro rata credit for opt outs. This amount was included as a component of “Restructuring and other charges (income)” in our consolidated statements of income for the year ended December 31, 2008. On July 14, 2009, the settlement received final approval by the Court. No appeal has been taken and the appeal period has expired. The Court has also approved a settlement with Arkema and finally approved settlements with four of the six original defendant-groups, who collectively paid approximately $90 million. Seventeen companies (predominantly paper producers) have opted out of certain of the settlements with other defendants. Certain of the defendants in the class action have settled those opt out claims for undisclosed amounts. Ten companies (again predominantly paper producers) have opted out of the settlements with FMC and Arkema. Eight of the ten remaining opt outs have filed suit against FMC and, in some cases, Foret. These cases have been assigned to the same judge as the class action, and the stay of these actions entered by the District Court during the class certification appeal remains in place. FMC has reached an agreement in principle to settle with two of the opt outs. Another individual opt out case was dismissed following the bankrupt opt out’s decision to participate in the class settlement. Most of the state court cases have been dismissed, although some remain in California. There has been no activity in the indirect purchaser class action but one indirect purchaser filed a claim in federal court in Kansas which has been transferred to the Eastern District of Pennsylvania and assigned to the same judge overseeing other hydrogen peroxide litigation. FMC has moved to dismiss this complaint on statute of limitations grounds. The motion is pending. In addition, putative class actions against the six major hydrogen peroxide producers have been filed in provincial courts in Ontario, Quebec and British Columbia under the laws of Canada. Four of the defendants have settled these claims for a total of approximately $20.5 million. On September 28, 2009, the Ontario Superior Court of Justice certified a class of direct and indirect purchasers of hydrogen peroxide. FMC intends to appeal the class certification decision and to defend these cases.

On January 19, 2009, the European Commission decided to initiate proceedings against FMC, its Netherlands subsidiary, and Foret, following an investigation of the European producers of animal feed phosphates. FMC is cooperating with the European Commission in the investigation and has recorded a charge of $21 million reflecting our best estimation of the expense that is likely to be incurred in connection with the resolution of this matter. This charge has been reflected as a component of “Restructuring and other charges (income)” in our condensed consolidated statements of income for the three and nine months ended September 30, 2009. This amount is included in “Accrued and other liabilities” on the condensed consolidated balance sheets as of September 30, 2009.

We have certain other contingent liabilities arising from litigation, claims, performance guarantees and other commitments incident to the ordinary course of business. Based on information currently available and established reserves, the ultimate resolution of our known contingencies, including the matters described in Note 19 to our condensed consolidated financial statements included in this Form 10-Q, is not expected to have a material adverse effect on our consolidated financial position or liquidity. However, there can be no assurance that the outcome of these contingencies will be favorable, and adverse results in certain of these contingencies could have a material adverse effect on our consolidated financial position, results of operations or liquidity.

### Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

### DERIVATIVE FINANCIAL INSTRUMENTS AND MARKET RISKS

Our earnings, cash flows, and financial position are exposed to market risks relating to fluctuations in commodity prices, interest rates and foreign currency exchange rates. Our policy is to minimize exposure to our cash flow over time caused by changes in commodity, interest and currency exchange rates. To accomplish this we have implemented a controlled program of risk management consisting of appropriate derivative contracts entered into with major financial institutions.

The analysis below presents the sensitivity of the market value of our financial instruments to selected changes in market rates and prices. The range of changes chosen reflects our view of changes that are reasonably possible over a one-year period. Market-value estimates are based on the present value of projected future cash flows considering the market rates and prices chosen.

At September 30, 2009, our net financial instrument position was a net liability of $13.1 million compared to a net liability of $39.9 million at December 31, 2008. The change in the net financial instrument position was due to lower unrealized losses in both our foreign exchange and commodity portfolios.

### Commodity Price Risk

Energy costs are approximately 13 percent of our cost of sales and services and are well balanced among coal, electricity, and natural gas. We attempt to mitigate our exposure to increasing energy costs by hedging the cost of future deliveries of natural gas and by entering into fixed-price contracts for the purchase of coal and fuel oil. To analyze the effect of changing energy prices, we have performed a sensitivity analysis in which we assume an instantaneous 10 percent change in energy market prices from their levels at September 30, 2009 and December 31, 2008, with all other variables (including interest rates) held constant. A 10 percent increase in energy market prices would result in a decrease in the net liability position of $5.9 million at September 30, 2009 and a decrease in the net liability position of $7.6 million at December 31, 2008. As a result, the net liability positions at September 30, 2009 would become a net asset position. A 10 percent decrease in energy market prices would result in an increase in the net liability position of $5.0 million at September 30, 2009 and an increase in the net liability position of $7.6 million at December 31, 2008.

### Foreign Currency Exchange Rate Risk

The primary currencies for which we have exchange rate exposure are the U.S. dollar versus the euro, the U.S. dollar versus the Chinese yuan and the U.S. dollar versus the Brazilian real. Foreign currency debt and foreign exchange forward contracts are used in countries where we do business, thereby reducing our net asset exposure. Foreign exchange forward contracts are also used to hedge firm and highly anticipated foreign currency cash flows.

To analyze the effects of changing foreign currency rates, we have performed a sensitivity analysis in which we assume an instantaneous 10 percent change in the foreign currency exchange rates from their levels at September 30, 2009 and December 31, 2008, with all other variables (including interest rates) held constant. A 10 percent strengthening of the hedged currencies versus our functional currencies would result in an increase of the net liability position of $19.8 and $10.9 million at September 30, 2009, and

December 31, 2008, respectively. A 10 percent weakening of the hedged currencies versus our functional currencies would result in a decrease of the net liability position of $22.7 and $11.8 million at September 30, 2009, and December 31, 2008, respectively. As a result, the net liability positions at September 30, 2009 would become a net asset position.

### Interest Rate Risk

We use various strategies to manage our interest rate exposure, including entering into interest rate swap agreements. As of September 30, 2009 and December 31, 2008, we had no agreements in place.

Our debt portfolio, at September 30, 2009, is composed of 34 percent fixed-rate debt and 66 percent variable-rate debt. The variable-rate component of our debt portfolio principally consists of borrowings under our Domestic and European Credit Agreements, variable-rate industrial and pollution control revenue bonds, and foreign bank borrowings. Changes in interest rates affect different portions of our variable-rate debt portfolio in different ways.

Based on the variable-rate instruments in our debt portfolio at September 30, 2009, a one percentage point increase or decrease in interest rates then in effect would have increased or decreased interest expense for the first nine months of the year by $3.1 million.

## Market risk

As filed, 207 characters.

The information required by this item is provided in “Derivative Financial Instruments and Market Risks,” under ITEM 2 - Management’s Discussion and Analysis of Financial Condition and Results of Operations.

## Controls and procedures

As filed, 3,537 characters.

(a) Evaluation of disclosure controls and procedures. Based on management’s evaluation (with the participation of the Company’s Chief Executive Officer and Chief Financial Officer), the Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of the period covered by this report, the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) are effective to provide reasonable assurance that information required to be disclosed by the Company in reports filed or submitted under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and is accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

(b) Change in Internal Controls. There have been no changes in internal controls over financial reporting that occurred during the quarter ended September 30, 2009 that materially affected or are reasonably likely to materially affect, our internal control over financial reporting.

### REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

### Report of Independent Registered Public Accounting Firm

The Board of Directors

FMC Corporation:

We have reviewed the condensed consolidated balance sheet of FMC Corporation and subsidiaries as of September 30, 2009, and the related condensed consolidated statements of income for the three-month and nine-month periods ended September 30, 2009 and 2008 and the condensed consolidated statements of cash flows for the nine-month periods ended September 30, 2009 and 2008. These condensed consolidated financial statements are the responsibility of the Company’s management.

We conducted our reviews in accordance with the standards of the Public Company Accounting Oversight Board (United States). A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States), the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

Based on our reviews, we are not aware of any material modifications that should be made to the condensed consolidated financial statements referred to above for them to be in conformity with U.S. generally accepted accounting principles.

We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheet of FMC Corporation and subsidiaries as of December 31, 2008, and the related consolidated statements of income, changes in stockholders’ equity and cash flows for the year then ended (not presented herein) and in our report dated February 23, 2009, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of December 31, 2008, is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.

### /s/ KPMG LLP

Philadelphia, Pennsylvania

November 4, 2009

Filed Nov 4, 2009.
Source: SEC EDGAR, the filing index for accession 0001193125-09-223626. Last ingested by Listed: Nov 13, 2026, 16:31 ET. No prices; not investment advice.
